Open at 12:30PM on May 25, 2022
Open at 12:30PM on May 25, 2022close

I-Relief™ Hot & Cold Therapy Eye Mask With Thermabeads™

1 mask

For the relief of symptoms associated with blepharitis, dry eye disease, meibomian gland disease (MGD), styes and chalazia, as well as headaches, sinus pressure, tension, swelling and puffiness.

$ 45.00 CAD
Buy now
Available in-store
Details

Dry Eye Disease is one of the most common, yet underdiagnosed, ocular diseases. Early-onset dry eye disease is characterized by mild symptoms that are often ignored or mismanaged by patients. As a result, dry eye disease often goes undiagnosed until the symptoms worsen.

Eye care professionals recommend moist heat therapy as a form of supplementary treatment for people suffering from dry eyes and other conditions of the eyelid. Hot or cold compresses can provide immediate relief from discomfort, and consistent use over time can help increase blood circulation, stimulate lipid oil production and reduce tear evaporation, thereby improving overall ocular health.

I-RELIEF™ Hot & Cold Therapy Eye Mask with ThermaBeads™ can help patients manage their dry eye condition from the mildest of symptoms to more serious conditions, such as MGD or Blepharitis.

I-RELIEF™ Features

  • Temperature retaining ThermaBeads™ for lasting hot or cold therapy
  • Naturally-hydrating ThermaBeads™ for deep penetrating, moist heat therapy
  • Latex free & non-allergenic
  • Contouring shape for full contact
  • Elastic strap for a comfortable fit
  • Adjustable closure for proper compression
  • Soft cloth fabric for added comfort
  • Reusable, washable, and durable to last longer
  • Machine washable fabric slipcover protects mask from oils,
    makeup and dirt

Contains one(1) eye mask 8.6 in x 3.5 in (22cm x 9 cm) and one(1) protective fabric slipcover

I Med Pharma

I-MED Pharma Inc. is a privately held Canadian company, headquartered in Montreal, Quebec. Specializing in dry eye diagnosis and management, I-MED Pharma provides Ocular Surface Disease (OSD) solutions to Canadian ophthalmologists, optometrists, and the global eye care community.